Using a tracheal stent for conservative management of speaking valve‐associated tracheo‐oesophageal fistula

Cunnane, Max; Patil, Shirish; Sothinathan, R.; Walker, David T.; Gaulton, M; Pitkin, Lisa

doi:10.1111/coa.12796

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with tracheoesophageal fistula require higher breathing support, such as high-flow oxygen therapy and even ventilatorassisted ventilation, adequate drainage, anti-infection and other adjuvant treatment (20,21). Covering fistula with membranous tracheal stent are effective ways to relieve the pain of patients (22,23). Zhou et al and other studies also shown tracheal stenting can be reasonable solutions in tracheoesophageal fistulas (2,5,24).…”

Section: Discussionmentioning

confidence: 99%

Tracheal stent placement provides opportunity for subsequent anti-cancer therapy for cancer patients with malignant respiratory complications

Ma¹,

Yang²,

Gu³

et al. 2021

Ann Palliat Med

View full text Add to dashboard Cite

Background: Critically ill patients with severe acute dyspnea due to malignant tracheal stenosis or tracheoesophageal fistula often need advanced respiratory support. Tracheal stenting is an important palliative treatment of such patients. This study retrospectively analyzes the efficacy and outcomes of airway stenting in patients with tracheal stenosis or tracheoesophageal fistula.Methods: Patients underwent stenting from 2005 to 2018 in a single center were reviewed. Ninety-seven patients with malignant tracheal stenosis and/or tracheoesophageal fistula who underwent stenting were analyzed, all these patients had poor respiratory status. Results:The median survival time of patients after stent placement was 119 days. Forty-five patients were treated with anti-tumor therapy after placing the stent. Discharged intensive care unit (ICU) within 3 days and postoperative antitumor treatment were independent predictors for the survival time after tracheal stenting (P<0.05).Conclusions: Tracheal stent implantation played an important role for additional anti-cancer treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Tracheal stent placement provides opportunity for subsequent anti-cancer therapy for cancer patients with malignant respiratory complications

Ma¹,

Yang²,

Gu³

et al. 2021

Ann Palliat Med

View full text Add to dashboard Cite

show abstract

Efficacy and risk factors of stent placement in the treatment of malignant tracheoesophageal fistula

Wang,

Duan,

Liu

et al. 2024

Front. Oncol.

View full text Add to dashboard Cite

BackgroundDue to the low incidence of malignant tracheoesophageal fistula and the paucity of relevant clinical studies, the benefits of stent implantation have not been well documented. It remains unclear which factors may affect fistula closure.MethodsBetween January 2015 and January 2021, 344 patients who were diagnosed with malignant tracheoesophageal fistula at Zhongda Hospital, Southeast University, were retrospectively enrolled. Demographic and clinical data were collected. Risk factors for fistula closure identified by univariate analysis were further analyzed using multivariable logistic regression.ResultsA total of 288 patients were analyzed in this study, of which 94 were treated conservatively, 170 were treated with an esophageal stent, and 24 were treated with a tracheal stent. Among them, the delta Karnofsky’s performance status score values (after 2 weeks/before treatment [p = 0.0028], after 1 month/before treatment [p = 0.0103]) were significantly different between conservative and stent treatment. There was a significant reduction of pneumonia incidence in the stenting group (33.53%) compared to the conservative treatment group (77.05%) after one month (p <0.0001). In addition, the closure of fistulas was influenced by four independent risk factors: 1) treatment methods (p < 0.0001), 2) fistula size (p = 0.0003), 3) preoperative white blood cell count (p = 0.0042), and 4) preoperative Karnofsky’s performance status score (p = 0.0001).ConclusionsStent implantation has become an effective method for treating malignant tracheoesophageal fistula compared to conservative treatment. Additionally, stent implantation, smaller fistula size, lower preoperative white blood cell count, and higher preoperative Karnofsky’s performance status score suggest a better outcome.

show abstract

Using a tracheal stent for conservative management of speaking valve‐associated tracheo‐oesophageal fistula

Cited by 2 publications

References 3 publications

Tracheal stent placement provides opportunity for subsequent anti-cancer therapy for cancer patients with malignant respiratory complications

Tracheal stent placement provides opportunity for subsequent anti-cancer therapy for cancer patients with malignant respiratory complications

Efficacy and risk factors of stent placement in the treatment of malignant tracheoesophageal fistula

Contact Info

Product

Resources

About